Maria de Miguel, MD
Internal Medicine · New York, NYNPI 1699935999
Payments from drug & device makers
Across 14 payments — averaging $30,599 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biontech SE$418K
- Alkermes, Inc.$10K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biontech SE | 13 | $418,140 |
| Alkermes, Inc. | 1 | $10,250 |
How this compares
$428,390 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 247 | $255,596 |
| OzempicSemaglutide | 142 | $134,573 |
| JanuviaSitagliptin Phosphate | 72 | $64,606 |
| EntrestoSacubitril/Valsartan | 38 | $40,323 |
| RybelsusSemaglutide | 26 | $35,347 |
| EliquisApixaban | 40 | $35,342 |
| XareltoRivaroxaban | 37 | $32,185 |
| TradjentaLinagliptin | 25 | $30,700 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $28,581 |
| LinzessLinaclotide | 37 | $25,672 |
| TrulicityDulaglutide | 25 | $22,875 |
| FarxigaDapagliflozin Propanediol | 17 | $21,837 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $20,793 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $19,776 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 14 | $8,670 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- Sally LauNew York$8.4M
- Maria RubinsteinNew York$6.3M
- Dana RathkopfNew York$6M
- Eytan SteinNew York$5.8M
- James GreenwaldNew York$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.